|
chr1_-_159459814
|
5.062
|
|
APOA2
|
apolipoprotein A-II
|
|
chr1_-_159459999
|
4.317
|
NM_001643
|
APOA2
|
apolipoprotein A-II
|
|
chr12_-_9159707
|
4.009
|
|
A2M
|
alpha-2-macroglobulin
|
|
chr12_-_9159780
|
3.859
|
|
A2M
|
alpha-2-macroglobulin
|
|
chr11_-_114880275
|
3.401
|
NM_001098517
NM_014333
|
CADM1
|
cell adhesion molecule 1
|
|
chr12_-_9159789
|
3.297
|
NM_000014
|
A2M
|
alpha-2-macroglobulin
|
|
chr17_-_61655915
|
3.202
|
NM_000042
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
chr5_-_42847716
|
3.129
|
NM_001085486
NM_001093726
NM_005410
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
chr12_-_9159742
|
2.878
|
|
A2M
|
alpha-2-macroglobulin
|
|
chr7_+_134483305
|
2.859
|
NM_018295
|
TMEM140
|
transmembrane protein 140
|
|
chr10_-_101831579
|
2.856
|
NM_001308
|
CPN1
|
carboxypeptidase N, polypeptide 1
|
|
chr17_-_6958695
|
2.723
|
|
ASGR2
|
asialoglycoprotein receptor 2
|
|
chr1_-_20682541
|
2.530
|
|
|
|
|
chr17_-_6958773
|
2.371
|
NM_001181
NM_080912
NM_080913
|
ASGR2
|
asialoglycoprotein receptor 2
|
|
chr10_-_44794146
|
2.286
|
NM_007021
|
C10orf10
|
chromosome 10 open reading frame 10
|
|
chr10_+_63331018
|
2.235
|
NM_032199
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
chr8_-_119192985
|
2.152
|
NM_000127
|
EXT1
|
exostosin 1
|
|
chr1_-_92124064
|
2.117
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
chr1_-_20685314
|
2.065
|
NM_018584
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1
|
|
chr17_+_69939130
|
1.992
|
NM_022036
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C
|
|
chr11_+_73037382
|
1.875
|
NM_001130036
|
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1
|
|
chr7_+_134114957
|
1.765
|
|
CALD1
|
caldesmon 1
|
|
chr7_+_134114701
|
1.748
|
NM_004342
NM_033138
NM_033157
|
CALD1
|
caldesmon 1
|
|
chr10_-_52315390
|
1.743
|
|
A1CF
|
APOBEC1 complementation factor
|
|
chr2_-_165259334
|
1.707
|
|
COBLL1
|
COBL-like 1
|
|
chr3_+_189413414
|
1.694
|
NM_005578
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
chr1_-_92124201
|
1.657
|
NM_001195683
NM_003243
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
chr9_-_93164015
|
1.643
|
NM_001698
|
AUH
|
AU RNA binding protein/enoyl-CoA hydratase
|
|
chr9_-_93163965
|
1.639
|
|
AUH
|
AU RNA binding protein/enoyl-CoA hydratase
|
|
chr19_+_18357966
|
1.638
|
NM_004864
|
GDF15
|
growth differentiation factor 15
|
|
chr13_+_112825113
|
1.625
|
NM_000504
|
F10
|
coagulation factor X
|
|
chr10_-_52315436
|
1.602
|
NM_001198818
NM_001198819
NM_001198820
NM_014576
NM_138932
NM_138933
|
A1CF
|
APOBEC1 complementation factor
|
|
chr3_-_126088530
|
1.589
|
|
ITGB5
|
integrin, beta 5
|
|
chr7_-_87180499
|
1.567
|
NM_000927
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
chr2_-_188086612
|
1.508
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
chr3_-_95175588
|
1.464
|
NM_000313
|
PROS1
|
protein S (alpha)
|
|
chr15_+_97009194
|
1.462
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
chr7_+_94377145
|
1.438
|
NM_001166161
NM_001166162
NM_001166163
|
PPP1R9A
|
protein phosphatase 1, regulatory (inhibitor) subunit 9A
|
|
chr3_-_95175282
|
1.427
|
|
PROS1
|
protein S (alpha)
|
|
chr3_-_150569574
|
1.423
|
|
TM4SF1
|
transmembrane 4 L six family member 1
|
|
chr10_-_90740935
|
1.408
|
NM_001141945
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
chr8_-_134378630
|
1.335
|
NM_001135242
NM_006096
|
NDRG1
|
N-myc downstream regulated 1
|
|
chr8_+_40130143
|
1.320
|
NM_020130
|
C8orf4
|
chromosome 8 open reading frame 4
|
|
chr2_+_96845704
|
1.305
|
NM_017623
NM_199078
|
CNNM3
|
cyclin M3
|
|
chr22_+_36928972
|
1.302
|
NM_001161573
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
|
chr4_+_124537334
|
1.238
|
NM_199327
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila)
|
|
chr3_+_23962518
|
1.235
|
NM_001145425
|
NR1D2
|
nuclear receptor subfamily 1, group D, member 2
|
|
chrY_+_2769596
|
1.227
|
NM_001008
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1
|
|
chr11_+_22652894
|
1.213
|
NM_005256
|
GAS2
|
growth arrest-specific 2
|
|
chr1_-_27113018
|
1.178
|
NM_021969
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
chr15_-_58671929
|
1.140
|
NM_134262
|
RORA
|
RAR-related orphan receptor A
|
|
chr2_-_65447370
|
1.128
|
NM_001128210
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
chr3_-_187309442
|
1.091
|
NM_004454
|
ETV5
|
ets variant 5
|
|
chr3_-_150903749
|
1.088
|
NM_001168278
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
chr8_+_126511739
|
1.083
|
NM_025195
|
TRIB1
|
tribbles homolog 1 (Drosophila)
|
|
chr22_+_36928011
|
1.079
|
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
|
chr2_-_188127294
|
1.078
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
chr10_+_7785347
|
1.077
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
|
chr10_+_7785331
|
1.073
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
|
chr20_+_254205
|
1.072
|
NM_006943
|
SOX12
|
SRY (sex determining region Y)-box 12
|
|
chr2_-_165133239
|
1.071
|
|
GRB14
|
growth factor receptor-bound protein 14
|
|
chr14_-_73620912
|
1.068
|
NM_005589
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1
|
|
chr12_+_99391870
|
1.061
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
chr2_-_188127430
|
1.060
|
NM_001032281
NM_006287
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
chr12_+_99391681
|
1.039
|
NM_005123
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
chr22_+_19458378
|
1.026
|
NM_000185
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1
|
|
chr10_+_7785235
|
1.022
|
NM_002216
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
|
chr10_+_111975618
|
1.021
|
NM_005962
|
MXI1
|
MAX interactor 1
|
|
chr8_-_17811750
|
1.007
|
|
FGL1
|
fibrinogen-like 1
|
|
chr10_+_111959978
|
0.975
|
NM_001008541
|
MXI1
|
MAX interactor 1
|
|
chr6_+_17708483
|
0.972
|
NM_016255
|
FAM8A1
|
family with sequence similarity 8, member A1
|
|
chr2_+_176761552
|
0.971
|
NM_024501
|
HOXD1
|
homeobox D1
|
|
chr1_-_167822248
|
0.955
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
chr1_-_60164912
|
0.936
|
NM_000775
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
chr14_-_73620826
|
0.928
|
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1
|
|
chrY_+_2769630
|
0.927
|
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1
|
|
chr3_-_101316038
|
0.921
|
NM_001042459
NM_182909
|
FILIP1L
|
filamin A interacting protein 1-like
|
|
chr14_+_22136968
|
0.920
|
NM_022060
|
ABHD4
|
abhydrolase domain containing 4
|
|
chr1_+_225194622
|
0.914
|
|
ADCK3
|
aarF domain containing kinase 3
|
|
chr10_+_7785290
|
0.911
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
|
chr3_-_58497913
|
0.901
|
NM_003500
|
ACOX2
|
acyl-CoA oxidase 2, branched chain
|
|
chr1_-_167822334
|
0.895
|
NM_000130
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
chr5_-_16795336
|
0.895
|
|
MYO10
|
myosin X
|
|
chr1_+_227506751
|
0.884
|
NM_006542
|
SPHAR
|
S-phase response (cyclin related)
|
|
chr1_+_225194582
|
0.883
|
|
ADCK3
|
aarF domain containing kinase 3
|
|
chr12_-_69837831
|
0.880
|
|
TSPAN8
|
tetraspanin 8
|
|
chr1_+_225194616
|
0.873
|
|
ADCK3
|
aarF domain containing kinase 3
|
|
chr20_-_49818268
|
0.871
|
|
ATP9A
|
ATPase, class II, type 9A
|
|
chr1_-_85816520
|
0.866
|
NM_001134445
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
chr1_-_60165049
|
0.862
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
chr10_+_123912930
|
0.860
|
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
chr3_+_23961739
|
0.854
|
NM_005126
|
NR1D2
|
nuclear receptor subfamily 1, group D, member 2
|
|
chr1_-_12599934
|
0.851
|
NM_004753
|
DHRS3
|
dehydrogenase/reductase (SDR family) member 3
|
|
chr10_+_123913094
|
0.850
|
NM_006997
NM_206860
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
chr17_+_2627099
|
0.848
|
|
RAP1GAP2
|
RAP1 GTPase activating protein 2
|
|
chr1_-_24342158
|
0.847
|
NM_021258
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
|
chr12_-_101835026
|
0.842
|
|
PAH
|
phenylalanine hydroxylase
|
|
chr1_+_225194560
|
0.842
|
NM_020247
|
ADCK3
|
aarF domain containing kinase 3
|
|
chr10_-_54201400
|
0.838
|
NM_000242
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
chr14_-_93859394
|
0.832
|
NM_001756
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
chr16_-_55876075
|
0.829
|
NM_015993
|
PLLP
|
plasmolipin
|
|
chr3_-_115825742
|
0.821
|
NM_001164347
|
ZBTB20
|
zinc finger and BTB domain containing 20
|
|
chr20_-_49818306
|
0.820
|
NM_006045
|
ATP9A
|
ATPase, class II, type 9A
|
|
chr2_+_11591692
|
0.819
|
NM_014668
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
chr9_-_135922912
|
0.817
|
NM_007371
|
BRD3
|
bromodomain containing 3
|
|
chr20_+_43468617
|
0.815
|
NM_001048223
NM_001048224
|
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2
|
|
chr16_-_55876099
|
0.794
|
|
PLLP
|
plasmolipin
|
|
chr9_-_135923373
|
0.782
|
|
BRD3
|
bromodomain containing 3
|
|
chr2_+_101680594
|
0.778
|
NM_004834
NM_145686
NM_145687
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
|
chr9_-_134809816
|
0.768
|
NM_000368
NM_001162426
NM_001162427
|
TSC1
|
tuberous sclerosis 1
|
|
chr4_+_140806536
|
0.763
|
|
MGST2
|
microsomal glutathione S-transferase 2
|
|
chr13_-_40138607
|
0.752
|
NM_002015
|
FOXO1
|
forkhead box O1
|
|
chr5_-_111119846
|
0.752
|
NM_001142483
|
C5orf13
|
chromosome 5 open reading frame 13
|
|
chr19_-_7244876
|
0.736
|
NM_000208
NM_001079817
|
INSR
|
insulin receptor
|
|
chr8_-_13018123
|
0.734
|
NM_001164271
|
DLC1
|
deleted in liver cancer 1
|
|
chr4_+_140806371
|
0.728
|
NM_002413
|
MGST2
|
microsomal glutathione S-transferase 2
|
|
chr12_-_51629874
|
0.720
|
|
KRT8
|
keratin 8
|
|
chr20_+_44771532
|
0.719
|
NM_030777
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10
|
|
chr20_+_21054623
|
0.715
|
NM_001163022
NM_001163023
NM_018474
|
PLK1S1
|
polo-like kinase 1 substrate 1
|
|
chr18_+_58533597
|
0.714
|
NM_194449
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
chr11_-_101828563
|
0.704
|
NM_052932
|
TMEM123
|
transmembrane protein 123
|
|
chr14_+_23653819
|
0.685
|
NM_025230
|
DCAF11
|
DDB1 and CUL4 associated factor 11
|
|
chr11_+_101488380
|
0.682
|
NM_001195045
|
YAP1
|
Yes-associated protein 1
|
|
chr2_+_73973600
|
0.681
|
NM_001615
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
|
chr20_-_33705244
|
0.673
|
NM_003915
|
CPNE1
|
copine I
|
|
chr14_+_23653848
|
0.673
|
|
DCAF11
|
DDB1 and CUL4 associated factor 11
|
|
chr1_-_27689129
|
0.670
|
|
WASF2
|
WAS protein family, member 2
|
|
chr14_+_23653745
|
0.669
|
NM_001163484
|
DCAF11
|
DDB1 and CUL4 associated factor 11
|
|
chr17_+_38306339
|
0.667
|
NM_000151
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
chr11_+_46358909
|
0.658
|
NM_001012334
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
chr18_+_64616296
|
0.656
|
NM_024781
|
CCDC102B
|
coiled-coil domain containing 102B
|
|
chr2_+_73973640
|
0.654
|
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
|
chr14_+_23654161
|
0.648
|
|
DCAF11
|
DDB1 and CUL4 associated factor 11
|
|
chr6_+_123152044
|
0.635
|
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A
|
|
chr6_+_64403685
|
0.632
|
|
PHF3
|
PHD finger protein 3
|
|
chr12_-_55990512
|
0.630
|
NM_014925
|
R3HDM2
|
R3H domain containing 2
|
|
chr2_-_215967442
|
0.628
|
|
FN1
|
fibronectin 1
|
|
chr1_+_63861474
|
0.625
|
NM_001172818
|
PGM1
|
phosphoglucomutase 1
|
|
chr7_+_134114912
|
0.624
|
|
CALD1
|
caldesmon 1
|
|
chr17_+_50699965
|
0.620
|
|
HLF
|
hepatic leukemia factor
|
|
chr12_-_69838045
|
0.617
|
NM_004616
|
TSPAN8
|
tetraspanin 8
|
|
chr8_-_28299850
|
0.609
|
NM_018660
|
ZNF395
|
zinc finger protein 395
|
|
chr3_-_79899748
|
0.609
|
NM_002941
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
chr16_-_55875953
|
0.607
|
|
PLLP
|
plasmolipin
|
|
chrX_+_146801142
|
0.605
|
NM_001185075
NM_001185076
NM_001185081
NM_001185082
NM_002024
|
FMR1
|
fragile X mental retardation 1
|
|
chr16_+_2593351
|
0.604
|
|
LOC652276
|
hypothetical LOC652276
|
|
chr4_+_155703581
|
0.596
|
NM_001184741
NM_005141
|
FGB
|
fibrinogen beta chain
|
|
chr7_+_65056876
|
0.596
|
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1
|
|
chr1_+_149897334
|
0.593
|
|
SNX27
|
sorting nexin family member 27
|
|
chr11_+_22644732
|
0.585
|
NM_001143830
|
GAS2
|
growth arrest-specific 2
|
|
chr1_+_144149794
|
0.580
|
NM_006472
|
TXNIP
|
thioredoxin interacting protein
|
|
chr14_+_49304533
|
0.576
|
NM_014315
|
KLHDC2
|
kelch domain containing 2
|
|
chr14_+_49304657
|
0.572
|
|
KLHDC2
|
kelch domain containing 2
|
|
chr17_-_62671767
|
0.571
|
NM_014877
|
HELZ
|
helicase with zinc finger
|
|
chr6_+_64403936
|
0.569
|
|
PHF3
|
PHD finger protein 3
|
|
chr18_-_490583
|
0.568
|
NM_130386
|
COLEC12
|
collectin sub-family member 12
|
|
chr10_-_90702490
|
0.562
|
NM_001613
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
chr14_+_23654307
|
0.561
|
NM_181357
|
DCAF11
|
DDB1 and CUL4 associated factor 11
|
|
chr22_-_30016707
|
0.559
|
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1
|
|
chr19_-_52426055
|
0.559
|
NM_014417
|
BBC3
|
BCL2 binding component 3
|
|
chr17_-_62671738
|
0.556
|
|
HELZ
|
helicase with zinc finger
|
|
chr6_+_64414389
|
0.552
|
NM_015153
|
PHF3
|
PHD finger protein 3
|
|
chr16_-_56389176
|
0.548
|
NM_001130099
|
KIFC3
|
kinesin family member C3
|
|
chr17_-_23686566
|
0.547
|
NM_174887
|
IFT20
|
intraflagellar transport 20 homolog (Chlamydomonas)
|
|
chr6_+_64403631
|
0.545
|
|
PHF3
|
PHD finger protein 3
|
|
chr10_+_7785360
|
0.542
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
|
chr20_+_62357490
|
0.540
|
NM_001104925
NM_018257
|
PCMTD2
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
|
|
chr1_-_20179495
|
0.536
|
NM_000300
NM_001161727
NM_001161728
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
chr12_-_74711642
|
0.531
|
NM_007350
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
chr10_-_32257768
|
0.528
|
NM_018287
|
ARHGAP12
|
Rho GTPase activating protein 12
|
|
chr1_-_172153087
|
0.518
|
NM_000488
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
chr4_-_103901171
|
0.517
|
|
MANBA
|
mannosidase, beta A, lysosomal
|
|
chr2_+_109909139
|
0.506
|
NM_001164463
NM_005054
|
RGPD8
RGPD5
|
RANBP2-like and GRIP domain containing 8
RANBP2-like and GRIP domain containing 5
|
|
chr13_-_47885248
|
0.506
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
|
chr10_+_123738678
|
0.505
|
NM_206861
NM_206862
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
chr19_+_40321584
|
0.502
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
chr18_-_44729700
|
0.499
|
NM_001190822
|
SMAD7
|
SMAD family member 7
|
|
chr16_+_20328355
|
0.496
|
NM_017888
|
ACSM5
|
acyl-CoA synthetase medium-chain family member 5
|
|
chr10_-_92671005
|
0.496
|
NM_014391
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
chr19_-_50601406
|
0.494
|
NM_001142502
|
PPP1R13L
|
protein phosphatase 1, regulatory (inhibitor) subunit 13 like
|
|
chr17_+_54997667
|
0.490
|
NM_001166301
NM_024612
|
DHX40
|
DEAH (Asp-Glu-Ala-His) box polypeptide 40
|
|
chr1_-_158759606
|
0.488
|
NM_001184714
NM_001184715
NM_001184716
NM_052931
|
SLAMF6
|
SLAM family member 6
|
|
chr12_-_121767272
|
0.485
|
NM_006018
|
GPR109B
|
G protein-coupled receptor 109B
|
|
chr12_-_90100733
|
0.484
|
NM_001920
|
DCN
|
decorin
|
|
chr3_-_188935363
|
0.483
|
NM_001134738
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
chr2_+_17585287
|
0.480
|
NM_003385
|
VSNL1
|
visinin-like 1
|
|
chr2_+_200879040
|
0.476
|
NM_001100422
NM_001100424
NM_001100423
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like
|
|
chr22_-_30018329
|
0.475
|
NM_001135911
NM_052880
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1
|
|
chr1_-_56817823
|
0.474
|
NM_003713
|
PPAP2B
|
phosphatidic acid phosphatase type 2B
|
|
chr10_+_31650069
|
0.473
|
NM_001128128
NM_001174094
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
chr2_+_101874765
|
0.468
|
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
|
chr4_+_100704262
|
0.467
|
NM_000253
|
MTTP
|
microsomal triglyceride transfer protein
|
|
chr19_+_40322231
|
0.465
|
NM_005031
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
chr6_+_64403668
|
0.464
|
|
PHF3
|
PHD finger protein 3
|
|
chr19_+_40321567
|
0.462
|
NM_021902
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
chr3_+_54131731
|
0.456
|
NM_018398
|
CACNA2D3
|
calcium channel, voltage-dependent, alpha 2/delta subunit 3
|
|
chr12_-_31370305
|
0.456
|
|
FAM60A
|
family with sequence similarity 60, member A
|
|
chr13_-_37341859
|
0.455
|
NM_001135955
NM_001135956
NM_001135957
NM_001135958
NM_003306
NM_016179
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
chr3_+_54131613
|
0.453
|
|
CACNA2D3
|
calcium channel, voltage-dependent, alpha 2/delta subunit 3
|
|
chr7_-_6065199
|
0.452
|
|
EIF2AK1
|
eukaryotic translation initiation factor 2-alpha kinase 1
|
